| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |